Amgen Inc. (NASDAQ:AMGN)

Paying user area

Try for free

Amgen Inc. pages available for free this week:

• Balance Sheet: Assets 
• Analysis of Solvency Ratios 
• DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin 
• Common Stock Valuation Ratios 
• Price to FCFE (P/FCFE) 
• Capital Asset Pricing Model (CAPM) 
• Return on Equity (ROE) since 2005 
• Debt to Equity since 2005 
• Price to Sales (P/S) since 2005 
• Analysis of Debt 

The data is hidden behind: . Unhide it.

• Get full access to the entire website from $10.42/mo, or

• get 1-month access to Amgen Inc. for $24.99.

Get access

This is a one-time payment. There is no automatic renewal.

---

We accept:

Amgen Inc., common-size consolidated income statement (quarterly data)

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).